Combining immunotherapy and radiation therapy may be a powerful treatment approach for castration-resistant prostate cancer.
News: Prostate Cancer
Vanderbilt collaborators focused on minimally invasive prostate surgery are developing an endoscopic robotic system with two-handed dexterity at a much smaller scale than existing options.
Austin Kirschner, MD, PhD, and colleagues have studied the mechanism of radiation sensitization for enzalutamide using multiple models of human prostate cancer.
The Vanderbilt Institute for Surgery and Engineering (VISE) team of Robert Webster III, PhD, and Duke Herrell, MD, have received a $2.2 million grant from the National Institutes of Health to develop a new surgical robot for endoscopic transurethral prostatectomy.
Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.
Vanderbilt urologic surgeons are offering an alternative therapy for prostate cancer patients considered to be low-to-intermediate risk, a middle ground between active surveillance and aggressive therapy.
Making sense of the updated guidelines for prostate cancer screening.
Longtime Vanderbilt-Ingram Cancer Center supporter Orrin Ingram opted to take an aggressive approach to treatment when he was diagnosed with prostate cancer.
If a career in medicine hadn’t worked out for Sam Chang, he might have been a politician. As an undergraduate at Princeton University, Chang chose to major in politics instead of common premed majors such as biology or chemistry. That way, he would have the opportunity to take a spectrum of liberal arts classes, from […]
A federal task force has changed its recommendation about prostate cancer screening for some older men. The United States Preventive Services Task Force (USPSTF) now recommends that men between the ages of 55 to 69 consult with their physicians about getting routine screening blood tests to detect prostate cancer. In 2012 the task force recommended […]